MK Biotech Revolution
Martin Kraus
| MAKER
Last Login: 04/17/2024
-48.5%
since 12/9/2020
-
Ø-Perf. per year
-
Performance (1yr)
-
Volatility (1yr)
-
Return/Risk
Portfolio chart
DetailsFeed
Trading Idea
Companies within this Wikifolio shall be focused on and are expected to substantially benefit from extending and enhancing the quality of human and other life by incorporating technological and scientific developments and advancements in genomics into their business. The companies shall be held in this Wikifolio may develop, produce or enable: CRISPR Targeted Therapeutics Bioinformatics Molecular Diagnostics Stem Cells Agricultural Biology Decisions to invest will be based on fundamental criteria as well as chart analysis.
Master data
Symbol
WFGENEREVO
Date created
12/09/2020
Index level
-
High watermark
75.8